Drug Replacement and Maintenance Therapy

Drug replacement and maintenance therapy have a long history of providing individuals struggling with problematic drug use with legal access to drugs that would otherwise be obtained through illegal means.  The Centers for Disease Control and Prevention, the Institute of Medicine, the Substance Abuse and Mental Health Service Administration (SAMHSA), the National Institute on Drug Abuse (NIDA), the World Health Organization and over four decades of government-funded, peer-reviewed medical research have unequivocally and repeatedly proven that replacement therapies like methadone maintenance are the most effective treatments for opioid dependence.
 

Harm Reduction and Human Rights: Strategies on Expanding Harm Reduction Through Human Rights

May 20, 2015

Watch the recording now!

Harm reduction services and syringe exchange are more than just a prevention strategy. Access to these vital services enables HIV testing, linkage to care and other critical health/social services, as well as affirming the human rights and dignity of people who use drugs.

NJ Governor Chris Christie Signs Bill Expanding Access to Evidence-Based Drug Treatment for Participants in Drug Courts

Legislation Permits Participants to Complete Drug Court While Using Medication Assisted Treatment Such as Methadone and Buprenorphine

Advocates Cheer Signing as Triumph of Good Public Health Policy and Lifesaving Reform

Trenton—Today Governor Chris Christie signed into law Senate Bill 2381/Assembly Bill 3723, which permits successful completion of drug court for those who are utilizing medication assisted treatment (MAT) for substance use disorders. The legislation gained bipartisan sponsorship and unanimous approval in the Legislature before reaching the Governor’s desk.

Contact:

Tony Newman 646-335-5384
Roseanne Scotti 609-610-8243

Prestigious Study Found Heroin-Assisted Treatment Produces Benefits to Individuals and Society

Study Focused on Six Countries and Found Reductions in Illegal Drug Use, Crime and Health Care Costs Without Harming Public Safety

Nevada State Senate Considered Legislation for Heroin-Assisted Treatment Trial Project

A seminal review recently published in the prestigious British Journal of Psychiatry confirms that heroin-assisted treatment, also known as supervised injectable heroin treatment or heroin-maintenance, is an effective treatment for patients who have not responded to standard treatment options such as methadone or residential rehabilitation. Heroin-assisted treatment refers to the supervised administration of pharmaceutical-grade heroin to a small group of particularly difficult-to-treat chronic heroin users.

Contact:

Lindsay LaSalle 510-847-8064
Tony Newman 646-335-5384

Testimony of Ethan Nadelmann in Support of a Heroin-assisted Treatment Pilot Program in Nevada

April 7, 2015

On April 7, 2015, Ethan Nadelmann, Executive Director of the Drug Policy Alliance, presented oral testimony in support of sections 11-20 of SB275 at a hearing of the Nevada State Senate Revenue and Economic Development Committee. Nadelmann also submitted complementary written testimony. SB275 would create a four-year heroin-assisted treatment pilot program—the first in the United States. Heroin-assisted treatment is a feasible, effective, and cost-saving strategy for reducing drug use and drug-related harm among long-term heroin users for whom other treatment programs have failed.

Colorado Opioid Symposium: Reducing the Impacts of Opioids in Colorado

Members of the Affected Community, International Experts, Treatment Providers, State Leaders and Physicians Gather to Discuss Opioid Use, Harm Reduction Strategies, Overdose Prevention, Supervised Injection Facilities, Heroin Assisted Treatment and Best Practices From Around the World

Daylong Symposium to be Held at Denver’s History Colorado Center, Thursday, March 5, 8:30 a.m. – 4:30 p.m.

Denver, CO – The Drug Policy Alliance, Harm Reduction Action Center and the Center for Public Health Practice will convene stakeholders to deliberate on the current impact of opioids and more effective responses to opioid use and dependency in Colorado.  The Opioid Symposium is a daylong event on Thursday, March 5th at the History Colorado Center in Denver.

Contact:

Art Way, 720-288-6924

Taking Control: Pathways to Drug Policies That Work

September 8, 2014
Global Commission on Drug Policy

This report reflects a new evolution in the thinking of the Global Commission, which includes Kofi Annan, Richard Branson, and the former presidents of Brazil, Chile, Colombia, Mexico, Poland, Portugal and Switzerland. They not only reiterate their demands for decriminalization, alternatives to incarceration, and greater emphasis on public health approaches – but now also call for responsible legal regulation of currently-illegal drugs.

Heroin-Assisted Treatment (HAT)

August 6, 2015

Under HAT, pharmacological heroin is administered under strict controls in a clinical setting to those who have failed in other treatments like methadone. Every published evaluation of HAT has shown extremely positive outcomes: major reductions in illicit drug use, crime, disease and overdose; and improvements in health, wellbeing, social reintegration and treatment retention. More than a half dozen countries in Europe and Canada have implemented heroin-assisted treatment (HAT) programs.

Stigma and People Who Use Drugs

March 3, 2014

There is an extensive body of literature documenting the stigma associated with alcohol and other drug problems. No physical or psychiatric condition is more associated with social disapproval and discrimination than substance dependence. For people who use drugs, or are recovering from problematic drug use, stigma can be a barrier to a wide range of opportunities and rights.

Healthcare Not Handcuffs: Putting the Affordable Care Act to Work for Criminal Justice and Drug Policy Reform

December 12, 2013
Drug Policy Alliance, American Civil Liberties Union

The Affordable Care Act (ACA) represents a remarkable opportunity for criminal justice and drug policy reform advocates to advance efforts to enact policy changes that promote safe and healthy communities, without excessively relying on criminal justice solutions that have become so prevalent under the war on drugs, and which fall so disproportionately on low-income communities and communities of color.

New Mexico's Medicaid Program to Cover Methadone for Opioid Addiction

New Mexico will join 30 other states in offering Medicaid Coverage for Methadone Maintenance Therapy

The State Finally Recognizes Methadone Maintenance Therapy as one of the Most Effective Treatments for Opioid Dependence and a Proven Way to Reduce Overdose Deaths

(SANTA FE, NM) – Starting September 1, the state of New Mexico’s Medicaid Program will begin to reimburse for outpatient Methadone Maintenance Therapy (MMT). New Mexico will join approximately 30 other states in offering Medicaid coverage for MMT.

Emily Kaltenbach 505-920-5256 or Steve Lucero 505-328-1391

Page 1 of 3
Syndicate content